Library
EndemicSER · SerologyHIV12

HIV-1/2 Ag/Ab combo

HIV-1/2

Last reviewed 2026-08-13

Public health significance

Still one of the most consequential results a PHL signs. The algorithm is the product, not the screen.

Specimen types

Serum, plasma

Method

Fourth-generation immunoassay

CLIA / validation

High complexity or moderate, depending on the platform. Differentiation and NAAT are part of the quality system.

Interpretation

Reactive / Nonreactive. A reactive screen is not a diagnosis and should not go to ELR alone.

Reflex / referral

HIV-1/2 differentiation, then NAAT if discordant, per CDC algorithm.

Quality control

Kit controls. External QC at a frequency matching volume and kit stability.

Reportability

Confirmed HIV is reportable. Screens are not cases.

HL7 / ELR

LOINC 56888-1 for the combo. Confirmatory assays get their own OBX rows.

Sources

CDC HIV laboratory testing algorithm.